Researchers sought to assess the importance of radiotherapy in pediatric patients with early‐stage low-risk classical Hodgkin lymphoma.
Researchers sought to determine whether response-adapted sequential salvage therapy would be effective in patients with relapsed/refractory classical Hodgkin lymphoma.
Researchers sought to determine the outcomes for patients with multiple myeloma who develop bacterial meningitis.
Zanubrutinib can improve progression-free survival, when compared with bendamustine-rituximab, in previously untreated CLL/SLL, a phase 3 trial suggests.
Among nonresponders to initial COVID-19 vaccination, seroconversion occurred in 56 percent following booster dose.